SHERIDAN, WYOMING, USA, February 27, 2022 /EINPresswire.com/ — According to IMARC Group’s latest report, titled “Acne Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global acne medication market reached a value of US$4.82 billion in 2020. Looking ahead, IMARC Group expects the market to grow at a CAGR of 4.4% during the period 2021-2026.
We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
Acne medications are medications used to treat a skin infection caused by inflammation of the hair follicles in the skin. It is usually caused by hormonal imbalance, oily skin, buildup of dead skin cells, bacteria, stress, insufficient fluid intake, and excessive consumption of sugars, salts, or carbohydrates. Few acne medications are topical medications, such as retinoids, salicylic and azelaic acid ointments, and dapsone gels, along with antibiotics, anti-androgens, and isotretinoin . These drugs reduce sebum production in the body, speed up skin cell turnover, reduce acne breakouts, scars, damage the skin and prevent inflammation.
Request a free sample report: https://www.imarcgroup.com/acne-drugs-market/requestsample
The increasing incidence of skin-related diseases, such as acne vulgaris, is driving the acne medication market. Additionally, increasing awareness about the benefits of using high-end skin care products and emergence of effective therapies and treatments with lesser side effects are augmenting the market growth. Additionally, the growing appeal of products with natural ingredients has compelled manufacturers to develop products infused with natural herbs and organic ingredients to treat acne. Additionally, rising consumer disposable income levels and rising popularity of personalized acne medications based on the user’s skin type are expected to propel the acne medication market.
Ask the analyst and browse the full report with table of contents and list of figures: https://bit.ly/3gaUbvu
List of key companies covered in this market report:
Bausch Health Companies Inc.
Cipher Pharmaceuticals Inc.
Galderma Holding SA
Johnson & Johnson
Reckitt Benckiser Plc Group
Skinvisible Pharmaceuticals Inc.
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd
The report has segmented the market based on acne type, drug class, drug type, route of administration and region.
Breakup by type of acne:
Breakdown by drug class:
Breakdown by type of drug:
Distribution by route of administration:
Breakdown by region:
Middle East and Africa
Main highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Porter’s Five Forces Analysis
Market drivers and success factors
Complete mapping of the competitive landscape
If you need specific information that is not currently covered in the report, we will provide it to you as part of the customization.
Browse related reports:
The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.
IMARC Services Private Limited
write to us here